title: Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues.
abstract: Microsatellite instability is a frequent (13%-24%) finding in sporadic endometrial adenocarcinoma and its precursor lesions, but most studies are limited to patients who already have malignant or premalignant endometrial disease. We performed retrospective testing for microsatellite instability in women in whom cancers showing microsatellite instability developed later and prospective testing in randomly selected normal and anovular endometrial biopsy specimens. Microsatellite instability in cancer-bearing biopsy specimens accurately reflected that seen in matched malignant tissues obtained at hysterectomy. In 1 patient, microsatellite instability developed in a scanty sample of fragmented endometrial tissues 7 years before the onset of endometrial cancer. Prospective testing for microsatellite instability in the endometria of women unselected for subsequent appearance of endometrial cancer showed a very low rate of microsatellite instability. Only 1 endometrial specimen showing microsatellite instability was found among 75 anovulatory endometrial specimens, and none were found in 377 normal endometrial specimens and 46 polyps examined. Microsatellite instability may precede the onset of histologically diagnosed carcinoma but is rare in randomly sampled histologically normal endometrial tissues.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115USA.
authors.forename: W C
authors.initials: WC
authors.lastname: Faquin
authors.forename: J T
authors.initials: JT
authors.lastname: Fitzgerald
authors.forename: M C
authors.initials: MC
authors.lastname: Lin
authors.forename: K A
authors.initials: KA
authors.lastname: Boynton
authors.forename: M G
authors.initials: MG
authors.lastname: Muto
authors.forename: G L
authors.initials: GL
authors.lastname: Mutter
mesh_terms: D018269:Carcinoma, Endometrioid / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D003475:Curettage; D017931:DNA Primers / Q000737:chemistry; D004273:DNA, Neoplasm / Q000032:analysis; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D004717:Endometrium / Q000187:drug effects / Q000473:pathology*; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D007044:Hysterectomy; D018895:Microsatellite Repeats / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011230:Precancerous Conditions / Q000235:genetics* / Q000473:pathology; D011446:Prospective Studies; D012189:Retrospective Studies; D012680:Sensitivity and Specificity
chemical_list: D017931:DNA Primers; D004273:DNA, Neoplasm; D004967:Estrogens